Last update Oct. 12, 2022
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Naltrexone Hydrochloride in other languages or writings:
Naltrexone Hydrochloride belongs to this group or family:
Main tradenames from several countries containing Naltrexone Hydrochloride in its composition:
|Oral Bioavail.||20 (5 - 40)||%|
|Tmax||1 - 2||hours|
|T½||4 - 13||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is a specific opioid antagonist with actions similar to, but more potent and longer lasting than, those of naloxone. It is used in the treatment of opiate dependence, alcohol dependence, and obesity. Intravenous and oral administration.
It is excreted in breast milk in clinically insignificant amounts and no problems were observed in a 6-week-old infant whose mother had been taking it orally since pregnancy. Plasma levels in this infant were very low or below the limit of detection. (Chan 2004)
Experts authors consider the use of this medication compatible during breastfeeding (Hale, LactMed, Briggs 2015)
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable (LactMed, Sachs 2013), especially during the neonatal period and in the event of prematurity.